
Create a free account to unlock the results.

Popular Responses
Create a free account to unlock the results.

Create a free account to unlock the results.

Russia’s biotechnology company Enteromix has announced that its cancer vaccine achieved 100% efficacy in preclinical trials, with strong tumour-fighting ability and no safety issues, according to reports. While some view this as a major breakthrough, others urge caution due to the limited early-stage data. We’d like to know what you think.

Create a free account to unlock the results.

Create a free account to unlock the results.
Create a free account to unlock the results.

Create a free account to unlock the results.

Create a free account to unlock the results.

Create a free account to unlock the results.

Create a free account to unlock the results.
Popular Responses
Create a free account to unlock the results.
Create a free account to unlock the results.


Create a free account to unlock the results.

Create a free account to unlock the results.

Create a free account to unlock the results.
Create a free account to unlock the results.

Create a free account to unlock the results.